TMEM16A alternative splicing coordination in breast cancer

Ifeoma Ubby, Erica Bussani, Antonio Colonna, Giuseppe Stacul, Martina Locatelli, Paolo Scudieri, Luis Galietta, Franco Pagani

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: TMEM16A, also known as Anoctamin-1, is a calcium-activated chloride channel gene overexpressed in many tumors. The role of TMEM16A in cancer is not completely understood and no data are available regarding the potential tumorigenic properties of the multiple isoforms generated by alternative splicing (AS).Methods: We evaluated TMEM16A AS pattern, isoforms distribution and Splicing Coordination (SC), in normal tissues and breast cancers, through a semi-quantitative PCR-assay that amplifies transcripts across three AS exons, 6b, 13 and 15.Results: In breast cancer, we did not observe an association either to AS of individual exons or to specific TMEM16A isoforms, and induced expression of the most common isoforms present in tumors in the HEK293 Flp-In Tet-ON system had no effect on cellular proliferation and migration. The analysis of splicing coordination, a mechanism that regulates AS of distant exons, showed a preferential association of exon 6b and 15 in several normal tissues and tumors: isoforms that predominantly include exon 6b tend to exclude exon 15 and vice versa. Interestingly, we found an increase in SC in breast tumors compared to matched normal tissues.Conclusions: As the different TMEM16A isoforms do not affect proliferation or migration and do not associate with tumors, our results suggest that the resulting channel activities are not directly involved in cell growth and motility. Conversely, the observed increase in SC in breast tumors suggests that the maintenance of the regulatory mechanism that coordinates distant alternative spliced exons in multiple genes other than TMEM16A is necessary for cancer cell viability.

Original languageEnglish
Article number75
JournalMolecular Cancer
Volume12
Issue number1
DOIs
Publication statusPublished - Jul 16 2013

Fingerprint

Alternative Splicing
Exons
Protein Isoforms
Breast Neoplasms
Neoplasms
Chloride Channels
Genes
Cell Movement
Cell Survival
Maintenance
Cell Proliferation
Polymerase Chain Reaction
Growth

Keywords

  • Alternative splicing
  • Breast cancer
  • Splicing coordination
  • TMEM16A isoforms

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Oncology

Cite this

Ubby, I., Bussani, E., Colonna, A., Stacul, G., Locatelli, M., Scudieri, P., ... Pagani, F. (2013). TMEM16A alternative splicing coordination in breast cancer. Molecular Cancer, 12(1), [75]. https://doi.org/10.1186/1476-4598-12-75

TMEM16A alternative splicing coordination in breast cancer. / Ubby, Ifeoma; Bussani, Erica; Colonna, Antonio; Stacul, Giuseppe; Locatelli, Martina; Scudieri, Paolo; Galietta, Luis; Pagani, Franco.

In: Molecular Cancer, Vol. 12, No. 1, 75, 16.07.2013.

Research output: Contribution to journalArticle

Ubby, I, Bussani, E, Colonna, A, Stacul, G, Locatelli, M, Scudieri, P, Galietta, L & Pagani, F 2013, 'TMEM16A alternative splicing coordination in breast cancer', Molecular Cancer, vol. 12, no. 1, 75. https://doi.org/10.1186/1476-4598-12-75
Ubby I, Bussani E, Colonna A, Stacul G, Locatelli M, Scudieri P et al. TMEM16A alternative splicing coordination in breast cancer. Molecular Cancer. 2013 Jul 16;12(1). 75. https://doi.org/10.1186/1476-4598-12-75
Ubby, Ifeoma ; Bussani, Erica ; Colonna, Antonio ; Stacul, Giuseppe ; Locatelli, Martina ; Scudieri, Paolo ; Galietta, Luis ; Pagani, Franco. / TMEM16A alternative splicing coordination in breast cancer. In: Molecular Cancer. 2013 ; Vol. 12, No. 1.
@article{55d378519307404189674556badc5867,
title = "TMEM16A alternative splicing coordination in breast cancer",
abstract = "Background: TMEM16A, also known as Anoctamin-1, is a calcium-activated chloride channel gene overexpressed in many tumors. The role of TMEM16A in cancer is not completely understood and no data are available regarding the potential tumorigenic properties of the multiple isoforms generated by alternative splicing (AS).Methods: We evaluated TMEM16A AS pattern, isoforms distribution and Splicing Coordination (SC), in normal tissues and breast cancers, through a semi-quantitative PCR-assay that amplifies transcripts across three AS exons, 6b, 13 and 15.Results: In breast cancer, we did not observe an association either to AS of individual exons or to specific TMEM16A isoforms, and induced expression of the most common isoforms present in tumors in the HEK293 Flp-In Tet-ON system had no effect on cellular proliferation and migration. The analysis of splicing coordination, a mechanism that regulates AS of distant exons, showed a preferential association of exon 6b and 15 in several normal tissues and tumors: isoforms that predominantly include exon 6b tend to exclude exon 15 and vice versa. Interestingly, we found an increase in SC in breast tumors compared to matched normal tissues.Conclusions: As the different TMEM16A isoforms do not affect proliferation or migration and do not associate with tumors, our results suggest that the resulting channel activities are not directly involved in cell growth and motility. Conversely, the observed increase in SC in breast tumors suggests that the maintenance of the regulatory mechanism that coordinates distant alternative spliced exons in multiple genes other than TMEM16A is necessary for cancer cell viability.",
keywords = "Alternative splicing, Breast cancer, Splicing coordination, TMEM16A isoforms",
author = "Ifeoma Ubby and Erica Bussani and Antonio Colonna and Giuseppe Stacul and Martina Locatelli and Paolo Scudieri and Luis Galietta and Franco Pagani",
year = "2013",
month = "7",
day = "16",
doi = "10.1186/1476-4598-12-75",
language = "English",
volume = "12",
journal = "Molecular Cancer",
issn = "1476-4598",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - TMEM16A alternative splicing coordination in breast cancer

AU - Ubby, Ifeoma

AU - Bussani, Erica

AU - Colonna, Antonio

AU - Stacul, Giuseppe

AU - Locatelli, Martina

AU - Scudieri, Paolo

AU - Galietta, Luis

AU - Pagani, Franco

PY - 2013/7/16

Y1 - 2013/7/16

N2 - Background: TMEM16A, also known as Anoctamin-1, is a calcium-activated chloride channel gene overexpressed in many tumors. The role of TMEM16A in cancer is not completely understood and no data are available regarding the potential tumorigenic properties of the multiple isoforms generated by alternative splicing (AS).Methods: We evaluated TMEM16A AS pattern, isoforms distribution and Splicing Coordination (SC), in normal tissues and breast cancers, through a semi-quantitative PCR-assay that amplifies transcripts across three AS exons, 6b, 13 and 15.Results: In breast cancer, we did not observe an association either to AS of individual exons or to specific TMEM16A isoforms, and induced expression of the most common isoforms present in tumors in the HEK293 Flp-In Tet-ON system had no effect on cellular proliferation and migration. The analysis of splicing coordination, a mechanism that regulates AS of distant exons, showed a preferential association of exon 6b and 15 in several normal tissues and tumors: isoforms that predominantly include exon 6b tend to exclude exon 15 and vice versa. Interestingly, we found an increase in SC in breast tumors compared to matched normal tissues.Conclusions: As the different TMEM16A isoforms do not affect proliferation or migration and do not associate with tumors, our results suggest that the resulting channel activities are not directly involved in cell growth and motility. Conversely, the observed increase in SC in breast tumors suggests that the maintenance of the regulatory mechanism that coordinates distant alternative spliced exons in multiple genes other than TMEM16A is necessary for cancer cell viability.

AB - Background: TMEM16A, also known as Anoctamin-1, is a calcium-activated chloride channel gene overexpressed in many tumors. The role of TMEM16A in cancer is not completely understood and no data are available regarding the potential tumorigenic properties of the multiple isoforms generated by alternative splicing (AS).Methods: We evaluated TMEM16A AS pattern, isoforms distribution and Splicing Coordination (SC), in normal tissues and breast cancers, through a semi-quantitative PCR-assay that amplifies transcripts across three AS exons, 6b, 13 and 15.Results: In breast cancer, we did not observe an association either to AS of individual exons or to specific TMEM16A isoforms, and induced expression of the most common isoforms present in tumors in the HEK293 Flp-In Tet-ON system had no effect on cellular proliferation and migration. The analysis of splicing coordination, a mechanism that regulates AS of distant exons, showed a preferential association of exon 6b and 15 in several normal tissues and tumors: isoforms that predominantly include exon 6b tend to exclude exon 15 and vice versa. Interestingly, we found an increase in SC in breast tumors compared to matched normal tissues.Conclusions: As the different TMEM16A isoforms do not affect proliferation or migration and do not associate with tumors, our results suggest that the resulting channel activities are not directly involved in cell growth and motility. Conversely, the observed increase in SC in breast tumors suggests that the maintenance of the regulatory mechanism that coordinates distant alternative spliced exons in multiple genes other than TMEM16A is necessary for cancer cell viability.

KW - Alternative splicing

KW - Breast cancer

KW - Splicing coordination

KW - TMEM16A isoforms

UR - http://www.scopus.com/inward/record.url?scp=84880083236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880083236&partnerID=8YFLogxK

U2 - 10.1186/1476-4598-12-75

DO - 10.1186/1476-4598-12-75

M3 - Article

C2 - 23866066

AN - SCOPUS:84880083236

VL - 12

JO - Molecular Cancer

JF - Molecular Cancer

SN - 1476-4598

IS - 1

M1 - 75

ER -